DoW Peer Reviewed Medical, Technology/Therapeutic Development Award

The DoW Peer Reviewed Medical, Technology/Therapeutic Development Award is a product-driven award mechanism that aims to support the translation of promising preclinical findings into products for clinical applications. The award is intended to address the health care needs of military Service Members, Veterans, and their Families. The program expects the research proposed to take an already established proof-of-concept or prototype through the final stages of preclinical development, with the goal of a regulatory filing or translation of findings into clinical practice. • The award has a maximum period of performance of 4 years. • The total cost cap per award is $5.6M. • Approximately 12 awards are expected to be funded, with a total of $67.2M allocated. • The award is open to any type of entity, subject to any clarification in the text field entitled "Additional Information on Eligibility".